Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - NIAID
 More »

  • Intravenous Vaccine Proves Protective against Malaria
    In the August 8 online edition of Science , researchers representing the National Institute of Allergy and Infectious Diseases (NIAID) reported the results of a Phase I clinical ...
    8-8-2013
  • NIAID Grants MBio $1.4M to Develop POC HIV Diagnostic
    The National Institute of Allergy and Infectious Diseases (NIAID) has awarded Boulder, ... Ph.D., MBio Diagnostics' founder and CEO. NIAID is granting MBio Diagnostics $1.4 million ...
    7-22-2013
  • Three-Gene Signature Helps Predict Kidney Transplant Rejection
    should improve long-term outcomes for transplant recipients," National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D., said in a statement. ...
    7-5-2013
  • Nanoparticle-Based Vaccine Shows Broader, More Potent Flu Immunity
    Scientists at the National Institute of Allergy and Infectious Diseases' Vaccine Research Center today report on their generation of a self-assembling nanoparticle vaccine, which ...
    5-22-2013
  • Obama Budget: More NIH Grants, Higher FDA User Fees
    However, NIH shifted about $67.9 million of the $194.5 million difference to its National Institute of Allergy and Infectious Diseases (NIAID), toward grants to establish ...
    4-11-2013
  • Inovio Wins $3.5M NIAID Grant to Advance Vaccine Device
    of Allergy and Infectious Diseases (NIAID) to advance development of a ... The NIAID grant follows a 2011 Small Business Innovation Research grant, for which Inovio ...
    4-10-2013
  • VaxInnate Wins $2.2M NIAID Grant for Dengue Vaccine
    of Allergy and Infectious Diseases (NIAID) to fund the development of a recombinant ... grant and look forward to working with NIAID to develop a vaccine to prevent dengue," ...
    4-4-2013
  • Fraunhofer Center Wins Up to $9.9M for Next-Gen Anthrax Vaccines
    The combined product "has the potential for an improved vaccine," Vidadi Yusibov, the Fraunhofer center's executive director, said in a statement. NIAID funding to support ...
    12-4-2012
  • Altravax Awarded $3.45M from NIAID for HIV-1 Vaccine Research
    of Allergy and Infectious Diseases (NIAID) toward research on antibody-inducing ... In 2010, NIAID awarded Altravax two Small Business Innovation Research grants totaling ...
    12-4-2012
  • HIV-AIDS Vaccines: Where Are We Now and Where Are We Heading...
    of Allergy and Infectious Disease (NIAID) announced the first encouraging results ... of Health (NIH), and in particular NIAID, are to be commended for their commitment ...
    12-3-2012
  • Stem Cells Save Teeth
    research grant from NIAID to fund evaluation and development of VSELs as a potential countermeasure against radiation exposure resulting from nuclear accident or terrorism. ...
    11-20-2012
  • Needle-Free Anthrax Vaccine Wins NIAID Contract
    Pfenex won a National Institute of Allergy and Infectious Diseases (NIAID) contract worth ... Under terms of the NIAID contract Pfenex could receive further funding of up to $22.9 ...
    10-17-2012
  • Funds Won for C. difficile-Targeted Antibiotic
    of Allergic and Infectious Diseases (NIAID) to fund continued preclinical development ... of Allergic and Infectious Diseases (NIAID) to fund continued preclinical development ...
    10-1-2012
  • GenVec Slashes Workforce by 30%
    GenVec won an approximately $590,000 Phase I SBIR grant from the NIAID in May to support its RSV vaccine program. A couple of months earlier the firm was awarded a $600,000 NIAID ...
    9-25-2012
  • Two Viral Links to Chronic Fatigue Debunked
    of Allergy and Infectious Diseases (NIAID) to commission its own study under the ... Lipkin said in a statement by Columbia. NIAID investigation followed controversy over ...
    9-18-2012
  • More »

    Journal Articles

  • Workshop Summary: Novel Biomarkers for HIV Incidence Assay Development
    Usha K. Sharma, Marco Schito, Alex Welte, Christine Rousseau, Joseph Fitzgibbon, Brandon Keele, Stuart Shapiro, Andrew McMichael, David N. Burns
    AIDS Research and Human Retroviruses
    On May 4, 2011, the Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), sponsored a 1-day workshop to ...
  • Pilot Studies for Development of an HIV Subtype Panel for Surveillance...
    Mark Manak, Silvana Sina, Bharathi Anekella, Indira Hewlett, Eric Sanders-Buell, Viswanath Ragupathy, Jerome Kim, Marion Vermeulen, Susan L. Stramer, Ester Sabino, Piotr Grabarczyk, Nelson Michael, Sheila Peel, Patricia Garrett, Sodsai Tovanabutra, Michael P. Busch, Marco Schito
    AIDS Research and Human Retroviruses
    Abstract The continued global spread and evolution of HIV diversity pose significant challenges to diagnostics and vaccine strategies. NIAID partnered with the FDA, WRAIR, ...
  • NIAID Workshop on Flavivirus Immunity
    Alison D. Augustine, M. Cristina Cassetti, Francis A. Ennis, Eva Harris, William H. Hildebrand, Patricia M. Repik
    Viral Immunology
    NIAID Workshop on Flavivirus Immunity Viral Immunology Abstract On September 16, 2009, the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National ...
  • The NIAID Radiation Countermeasures Program Business Model
    Nathaniel Hafer, Bert W. Maidment, Richard J. Hatchett
    Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science
    The NIAID Radiation Countermeasures Program Business Model Biosecurity and Bioterrorism: ... The National Institute of Allergy and Infectious Diseases (NIAID) Radiation/Nuclear ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll